BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 30251378)

  • 1. Characterization of CRISPR-Cas systems in the Ralstonia solanacearum species complex.
    da Silva Xavier A; de Almeida JCF; de Melo AG; Rousseau GM; Tremblay DM; de Rezende RR; Moineau S; Alfenas-Zerbini P
    Mol Plant Pathol; 2019 Feb; 20(2):223-239. PubMed ID: 30251378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primed CRISPR-Cas Adaptation and Impaired Phage Adsorption in Streptococcus mutans.
    Mosterd C; Moineau S
    mSphere; 2021 May; 6(3):. PubMed ID: 34011685
    [No Abstract]   [Full Text] [Related]  

  • 3. Cooperation between Different CRISPR-Cas Types Enables Adaptation in an RNA-Targeting System.
    Hoikkala V; Ravantti J; Díez-Villaseñor C; Tiirola M; Conrad RA; McBride MJ; Moineau S; Sundberg LR
    mBio; 2021 Mar; 12(2):. PubMed ID: 33785624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Spacer and Protospacer Sequence Requirements in the Vibrio cholerae Type I-E CRISPR/Cas System.
    Bourgeois J; Lazinski DW; Camilli A
    mSphere; 2020 Nov; 5(6):. PubMed ID: 33208517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional Analysis of Bacteriophage Immunity through a Type I-E CRISPR-Cas System in Vibrio cholerae and Its Application in Bacteriophage Genome Engineering.
    Box AM; McGuffie MJ; O'Hara BJ; Seed KD
    J Bacteriol; 2016 Feb; 198(3):578-90. PubMed ID: 26598368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survey of clustered regularly interspaced short palindromic repeats and their associated Cas proteins (CRISPR/Cas) systems in multiple sequenced strains of Klebsiella pneumoniae.
    Ostria-Hernández ML; Sánchez-Vallejo CJ; Ibarra JA; Castro-Escarpulli G
    BMC Res Notes; 2015 Aug; 8():332. PubMed ID: 26238567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In through the Out Door: A Functional Virulence Factor Secretion System Is Necessary for Phage Infection in Ralstonia solanacearum.
    Xavier ADS; de Melo AG; Hendrich CG; Tremblay DM; Rousseau GM; Plante PL; Forest KT; Alfenas-Zerbini P; Allen C; Moineau S
    mBio; 2022 Dec; 13(6):e0147522. PubMed ID: 36314808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clustered Regularly Interspaced Short Palindromic Repeat-Dependent, Biofilm-Specific Death of Pseudomonas aeruginosa Mediated by Increased Expression of Phage-Related Genes.
    Heussler GE; Cady KC; Koeppen K; Bhuju S; Stanton BA; O'Toole GA
    mBio; 2015 May; 6(3):e00129-15. PubMed ID: 25968642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative Analysis of Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) of Streptococcus thermophilus St-I and its Bacteriophage-Insensitive Mutants (BIM) Derivatives.
    Li W; Bian X; Evivie SE; Huo GC
    Curr Microbiol; 2016 Sep; 73(3):393-400. PubMed ID: 27378131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Avoidance of Trinucleotide Corresponding to Consensus Protospacer Adjacent Motif Controls the Efficiency of Prespacer Selection during Primed Adaptation.
    Musharova O; Vyhovskyi D; Medvedeva S; Guzina J; Zhitnyuk Y; Djordjevic M; Severinov K; Savitskaya E
    mBio; 2018 Dec; 9(6):. PubMed ID: 30514784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization and comparison of CRISPR Loci in Streptococcus thermophilus.
    Hu T; Cui Y; Qu X
    Arch Microbiol; 2020 May; 202(4):695-710. PubMed ID: 31781808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Occurrence and activity of a type II CRISPR-Cas system in Lactobacillus gasseri.
    Sanozky-Dawes R; Selle K; O'Flaherty S; Klaenhammer T; Barrangou R
    Microbiology (Reading); 2015 Sep; 161(9):1752-1761. PubMed ID: 26297561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How type II CRISPR-Cas establish immunity through Cas1-Cas2-mediated spacer integration.
    Xiao Y; Ng S; Nam KH; Ke A
    Nature; 2017 Oct; 550(7674):137-141. PubMed ID: 28869593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Requirements for Pseudomonas aeruginosa Type I-F CRISPR-Cas Adaptation Determined Using a Biofilm Enrichment Assay.
    Heussler GE; Miller JL; Price CE; Collins AJ; O'Toole GA
    J Bacteriol; 2016 Nov; 198(22):3080-3090. PubMed ID: 27573013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional Analysis of Porphyromonas gingivalis W83 CRISPR-Cas Systems.
    Burmistrz M; Dudek B; Staniec D; Rodriguez Martinez JI; Bochtler M; Potempa J; Pyrc K
    J Bacteriol; 2015 Aug; 197(16):2631-41. PubMed ID: 26013482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel configurations of type I and II CRISPR-Cas systems in Corynebacterium diphtheriae.
    Sangal V; Fineran PC; Hoskisson PA
    Microbiology (Reading); 2013 Oct; 159(Pt 10):2118-26. PubMed ID: 23904149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of CRISPR/cas system in the development of bacteriophage resistance.
    Szczepankowska A
    Adv Virus Res; 2012; 82():289-338. PubMed ID: 22420856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRISPRals: A Web Database for Assessing the CRISPR Defense System in the
    Motoche-Monar C; Andrade D; Pijal WD; Hidrobo F; Armas R; Sánchez-Real E; Rocha-Chauca G; Castillo JA
    Phytopathology; 2024 Jun; ():PHYTO01240010SC. PubMed ID: 38427684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [CRISPR/Cas systems in genome engineering of bacteriophages].
    Liang CJ; Meng FM; Ai YC
    Yi Chuan; 2018 May; 40(5):378-389. PubMed ID: 29785946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adaptation in bacterial CRISPR-Cas immunity can be driven by defective phages.
    Hynes AP; Villion M; Moineau S
    Nat Commun; 2014 Jul; 5():4399. PubMed ID: 25056268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.